Profile | GDS5420 / 225280_x_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 704.96 | 73 |
GSM1296119 | B_lesional_pre-dose | 399.67 | 64 |
GSM1296076 | C_lesional_pre-dose | 312.47 | 61 |
GSM1296092 | D_lesional_pre-dose | 416.87 | 65 |
GSM1296103 | E_lesional_pre-dose | 668.18 | 72 |
GSM1296078 | F_lesional_pre-dose | 248.29 | 58 |
GSM1296107 | G_lesional_pre-dose | 379.48 | 63 |
GSM1296109 | H_lesional_pre-dose | 591.75 | 70 |
GSM1296080 | I_lesional_pre-dose | 478.1 | 67 |
GSM1296090 | J_lesional_pre-dose | 375.83 | 64 |
GSM1296074 | K_lesional_pre-dose | 330.59 | 62 |
GSM1296111 | L_lesional_pre-dose | 328.45 | 60 |
GSM1296099 | M_lesional_pre-dose | 513.17 | 68 |
GSM1296086 | O_lesional_pre-dose | 392.9 | 64 |
GSM1296117 | P_lesional_pre-dose | 409.62 | 64 |
GSM1296113 | Q_lesional_pre-dose | 391.74 | 63 |
GSM1296096 | R_lesional_pre-dose | 383.17 | 63 |
GSM1296105 | S_lesional_pre-dose | 624.27 | 71 |
GSM1296098 | T_lesional_pre-dose | 677.28 | 73 |
GSM1296101 | U_lesional_pre-dose | 704.34 | 73 |
GSM1296121 | V_lesional_pre-dose | 536.42 | 69 |
GSM1296088 | W_lesional_pre-dose | 438.05 | 65 |
GSM1296082 | X_lesional_pre-dose | 247.2 | 57 |
GSM1296115 | Y_lesional_pre-dose | 492.55 | 67 |
GSM1296084 | Z_lesional_pre-dose | 443.67 | 66 |
GSM1296072 | B_lesional_day8 | 535.6 | 69 |
GSM1296069 | L_lesional_day8 | 435.89 | 65 |
GSM1296071 | P_lesional_day8 | 504.18 | 67 |
GSM1296070 | Y_lesional_day8 | 534.96 | 69 |
GSM1296073 | V_lesional_day8 | 397.63 | 64 |
GSM1296034 | A_lesional_day15 | 1088.45 | 81 |
GSM1296041 | G_lesional_day15 | 339.71 | 61 |
GSM1296035 | R_lesional_day15 | 481.08 | 67 |
GSM1296038 | U_lesional_day15 | 645.79 | 72 |
GSM1296047 | B_lesional_day15 | 566.84 | 70 |
GSM1296039 | E_lesional_day15 | 343.32 | 62 |
GSM1296042 | H_lesional_day15 | 480.73 | 67 |
GSM1296043 | L_lesional_day15 | 350.7 | 61 |
GSM1296037 | M_lesional_day15 | 894.79 | 77 |
GSM1296046 | P_lesional_day15 | 507.25 | 67 |
GSM1296044 | Q_lesional_day15 | 415.95 | 64 |
GSM1296045 | Y_lesional_day15 | 715.72 | 74 |
GSM1296025 | C_lesional_day15 | 929.13 | 78 |
GSM1296033 | D_lesional_day15 | 488.91 | 67 |
GSM1296027 | I_lesional_day15 | 346.12 | 62 |
GSM1296032 | J_lesional_day15 | 700.35 | 73 |
GSM1296024 | K_lesional_day15 | 786.44 | 75 |
GSM1296031 | W_lesional_day15 | 741.13 | 74 |
GSM1296028 | X_lesional_day15 | 571.11 | 70 |
GSM1296029 | Z_lesional_day15 | 629.98 | 71 |
GSM1296026 | F_lesional_day15 | 406.87 | 65 |
GSM1296030 | O_lesional_day15 | 480.74 | 67 |
GSM1296040 | S_lesional_day15 | 689.41 | 73 |
GSM1296036 | T_lesional_day15 | 681.78 | 72 |
GSM1296048 | V_lesional_day15 | 523.71 | 69 |
GSM1296059 | A_lesional_day43 | 626.12 | 71 |
GSM1296066 | G_lesional_day43 | 372.67 | 62 |
GSM1296060 | R_lesional_day43 | 536.53 | 69 |
GSM1296063 | U_lesional_day43 | 478.72 | 67 |
GSM1296064 | E_lesional_day43 | 385.46 | 64 |
GSM1296067 | H_lesional_day43 | 679.19 | 73 |
GSM1296062 | M_lesional_day43 | 777.11 | 75 |
GSM1296068 | Q_lesional_day43 | 451.9 | 65 |
GSM1296050 | C_lesional_day43 | 558.98 | 70 |
GSM1296057 | D_lesional_day43 | 781.76 | 75 |
GSM1296052 | I_lesional_day43 | 297.8 | 60 |
GSM1296054 | J_lesional_day43 | 706.35 | 73 |
GSM1296049 | K_lesional_day43 | 593.88 | 71 |
GSM1296055 | W_lesional_day43 | 771.96 | 75 |
GSM1296053 | X_lesional_day43 | 656.81 | 72 |
GSM1296058 | Z_lesional_day43 | 787.65 | 75 |
GSM1296051 | F_lesional_day43 | 351.68 | 63 |
GSM1296056 | O_lesional_day43 | 564.2 | 70 |
GSM1296065 | S_lesional_day43 | 497.26 | 67 |
GSM1296061 | T_lesional_day43 | 818.21 | 76 |
GSM1296095 | A_non-lesional_pre-dose | 420.55 | 65 |
GSM1296120 | B_non-lesional_pre-dose | 539.78 | 69 |
GSM1296077 | C_non-lesional_pre-dose | 956.21 | 78 |
GSM1296093 | D_non-lesional_pre-dose | 941.12 | 78 |
GSM1296104 | E_non-lesional_pre-dose | 441.96 | 66 |
GSM1296079 | F_non-lesional_pre-dose | 582.08 | 70 |
GSM1296108 | G_non-lesional_pre-dose | 473.68 | 67 |
GSM1296110 | H_non-lesional_pre-dose | 664.49 | 72 |
GSM1296081 | I_non-lesional_pre-dose | 1031.82 | 79 |
GSM1296091 | J_non-lesional_pre-dose | 463.42 | 67 |
GSM1296075 | K_non-lesional_pre-dose | 446.57 | 67 |
GSM1296112 | L_non-lesional_pre-dose | 505.27 | 67 |
GSM1296100 | M_non-lesional_pre-dose | 1281.39 | 83 |
GSM1296087 | O_non-lesional_pre-dose | 477.62 | 67 |
GSM1296118 | P_non-lesional_pre-dose | 687.07 | 73 |
GSM1296114 | Q_non-lesional_pre-dose | 414.69 | 64 |
GSM1296097 | R_non-lesional_pre-dose | 503.41 | 68 |
GSM1296106 | S_non-lesional_pre-dose | 859.11 | 77 |
GSM1296102 | U_non-lesional_pre-dose | 960.17 | 78 |
GSM1296122 | V_non-lesional_pre-dose | 627.64 | 71 |
GSM1296089 | W_non-lesional_pre-dose | 767.32 | 75 |
GSM1296083 | X_non-lesional_pre-dose | 1144.09 | 81 |
GSM1296116 | Y_non-lesional_pre-dose | 675.37 | 73 |
GSM1296085 | Z_non-lesional_pre-dose | 591.76 | 70 |